e.g. Tata motors, Reliance MF, 500570

Sun Pharmaceutical Industries Ltd. - Research Center

524715 SUNPHARMA Group (A) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 26 Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22
Income
Operating income 20,754.64 23,003.33 20,275.17 20,812.14 15,585.98
Expenses
Material consumed 6,021.74 6,469.84 6,083.35 6,476.17 6,193.54
Manufacturing expenses 488.71 435.72 794.87 808.96 697.56
Personnel expenses 2,911.30 2,608.26 2,373.95 2,156.95 2,000.78
Selling expenses - - - - -
Adminstrative expenses 5,152.20 6,696.89 5,435.39 4,897.20 3,786.58
Expenses capitalised - - - - -
Cost of sales 14,573.95 16,210.71 14,687.56 14,339.28 12,678.46
Operating profit 6,180.69 6,792.62 5,587.61 6,472.86 2,907.52
Other recurring income 419.33 369.43 465.76 279.03 957.92
Adjusted PBDIT 6,600.02 7,162.05 6,053.37 6,751.89 3,865.44
Financial expenses 947.84 893.21 784.08 472.18 388.10
Depreciation 1,311.72 1,238.27 1,600.62 1,600.87 1,349.95
Other write offs - - - - -
Adjusted PBT 4,340.46 5,030.57 3,668.67 4,678.84 2,127.39
Tax charges 1,170.70 747.95 591.47 50.33 406.85
Adjusted PAT 3,169.76 4,282.62 3,077.20 4,628.51 1,720.54
Non recurring items -549.08 11.87 -238.88 -2,930.41 -1,835.06
Other non cash adjustments - - - - -
Reported net profit 2,620.68 4,294.49 2,838.32 1,698.10 -114.52
Earnigs before appropriation 15,568.69 17,025.53 15,629.20 15,310.18 15,850.03
Equity dividend 3,933.90 3,613.97 2,898.16 2,519.30 2,158.91
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 11,634.79 13,411.56 12,731.04 12,790.88 13,691.12
Close
Add Sun Pharmaceutical Industries Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Sun Pharmaceutical Industries Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback